Here are the links to the websites for next Tuesday’s Journal Club.
EFFICACY AND SAFETY OF RECOMBINANT HUMAN ACTIVATED PROTEIN C FOR SEVERE SEPSIS
EARLY GOAL-DIRECTED THERAPY IN THE TREATMENT OF SEVERE SEPSIS
prospective_trial_of_supranormal_values_of_survivors_as_therapeutic_goals_in_high-risk_surgical_patients
Journal Club Assessment Form
Thursday, October 11, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment